MS News that Caught My Eye Last Week: AHSCT Trial Enlisting, Interferon-beta and Pregnancy, Probiotics, Language and Brain Health
New Trial Compares Stem Cell Treatment to Available Therapies for Severe Relapsing MS This is a biggie. The U.S. National Institutes of Health is conducting a head to head study comparing autologous hematopoietic stem cell transplantation (AHSCT) to the high-efficacy, disease-modifying therapies currently being used: Tysabri, Lemtrada, Ocrevus, and…